Invest now
Supha Pharmachem Ltd share price
High risk
You have to be logged in to add this to Watchlist.- ₹0.24(-4.00%)October 13, 2026 15:56:42 PM IST
- NSE
- BSE
- Vol : 1.73 M (NSE + BSE)Last 20 day avg : 1.36 M
Supha Pharmachem Ltd is trading -4.00% lower at Rs 0.24 as compared to its last closing price. Supha Pharmachem Ltd has been trading in the price range of 0.26 & 0.24. Supha Pharmachem Ltd has given -66.67% in this year & 0.00% in the last 5 days. Supha Pharmachem Ltd has TTM P/E ratio 11.83 as compared to the sector P/E of 34.46.The company posted a net profit of 8.62 Crores in its last quarter.Listed peers of Supha Pharmachem Ltd include Sun Pharmaceutical Industries (0.57%), Divi's Laboratories (-1.11%), Torrent Pharmaceuticals (-0.94%).The Mutual Fund holding in Supha Pharmachem Ltd was at -% in . The MF holding has - from the last quarter. The FII holding in Supha Pharmachem Ltd was at 1.70% in 31 Dec 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 14 Oct 2026, 06:13 AM IST
- BetaHigh volatility1.90Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry26.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.08The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Supha Pharmachem Ltd Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,769.10 | 0.57 | 4,24,456.35 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,275.00 | -1.11 | 2,46,222.10 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,635.00 | -0.94 | 1,76,294.19 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,330.00 | 1.24 | 1,07,446.79 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,131.00 | -0.70 | 1,12,817.68 | 21.19 | 4.24 | 0.09 | 14.22 |
Supha Pharmachem Ltd Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-03-30 | Quarterly Results |
| 2026-03-09 | Quarterly Results |
| 2026-02-25 | Quarterly Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
About the company Supha Pharmachem Ltd
- IndustryBiotechnology & Drugs
- ISININE549S01036
- BSE Code539561
- NSE Code
Supha Pharmachem Limited, formerly Remedium Lifecare Limited, is an India-based pharmaceutical and specialty chemicals company engaged in trading and distribution of raw materials for the pharmaceutical industry. The Company is engaged in the business of trading in advanced pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and other pharma products used viz. Isopropyl Alcohol (IPA) ,Cyclohexane, Diisopropyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Methylene Dichloride, Potassium Carbonate Powder, Sodium Bicarbonate, Potassium Hydroxide Flakes, Sodium Chloride (common salt), Sodium Carbonate (soda ash), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, and Trimethyl Sulfoxonium Iodide (TMSI).
Supha Pharmachem Ltd Share Price FAQs
Supha Pharmachem Ltd is trading at 0.24 as on Tue Oct 13 2026 10:26:42. This is -4.00% lower as compared to its previous closing price of 0.25.
The market capitalization of Supha Pharmachem Ltd is 21.16 Cr as on Tue Oct 13 2026 10:26:42.
The 52 wk high for Supha Pharmachem Ltd is 1.80 whereas the 52 wk low is 0.24
Supha Pharmachem Ltd can be analyzed on the following key metrics -
- TTM P/E: 11.83
- Sector P/E: 34.46
- Dividend Yield: 0.00%
- D/E ratio: 10.34
Supha Pharmachem Ltd reported a net profit of 2.13 Cr in 2025.
Quick Links
EQUITY QUICK LINKS
Supha Pharmachem Ltd QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.